Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Fulcrum Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for FULC.
You can purchase shares of Fulcrum Therapeutics (NASDAQ:FULC) through any online brokerage.
Other companies in Fulcrum Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Third Harmonic Bio (NASDAQ:THRD), Bioage Labs (NASDAQ:BIOA), Rapport Therapeutics (NASDAQ:RAPP) and Terns Pharma (NASDAQ:TERN).
Fulcrum Therapeutics has a consensus price target of $7.50.
The stock price for Fulcrum Therapeutics (NASDAQ: FULC) is $3.24 last updated March 4, 2025 at 6:08 AM EST.
There are no upcoming dividends for Fulcrum Therapeutics.
Fulcrum Therapeutics’s Q1 earnings are confirmed for Monday, May 12, 2025.
There is no upcoming split for Fulcrum Therapeutics.
Fulcrum Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.